Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimen.

AIDS (London, England) - 1 Oct 2008

Roquebert Bénédicte, Blum Laurent, Collin Gilles, Damond Florence, Peytavin Gilles, Leleu Juliette, Matheron Sophie, Chêne Geneviève, Brun-Vézinet Françoise, Descamps Diane

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Viral
Share to HIV-2
Share to HIV Infections
Share to HIV Integrase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Integrase Inhibitors

Share to Pyrrolidinones

Share to Raltegravir Potassium

Share to Treatment Failure

Source

Identifiers

PMID: 18784469
DOI: 10.1097/QAD.0b013e32830f4c7d

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimen.PMID 18784469Read ↗

Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy.Semantic proximity Read ↗

Impact of the HIV-1 genetic background and HIV-1 population size on the evolution of raltegravir resistanceSemantic proximity Read ↗

Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruptionSemantic proximity Read ↗

Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure.Semantic proximity Read ↗

[Resistance to integrase inhibitors].Semantic proximity Read ↗

Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressureSemantic proximity Read ↗

Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravir.Semantic proximity Read ↗

Selective-advantage profile of human immunodeficiency virus type 1 integrase mutants explains in vivo evolution of raltegravir resistance genotypes.Semantic proximity Read ↗

Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies.Semantic proximity Read ↗

Selection of resistance mutations in children receiving prophylaxis with lamivudine or nevirapine for the prevention of postnatal transmission of HIV.Semantic proximity Read ↗

Selection of L74V mutation in reverse transcriptase of HIV-1 subtype D by a tenofovir DF-lamivudine based regimen.Semantic proximity Read ↗

Plasma raltegravir exposure influences the antiviral activity and selection of resistance mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.